Two More Quality Growth Stocks from Screen (CELG, MR)

I recently ran a Growth Screen and found two stocks at the top of the screen.

1. Celgene (CELG): Biotech company has a forward PE of 33 and a 5 year estimated growth of 35.79%, for a low PEG of 0.92. Stock is near very near its 52 week high or has just broken above recent high.
   
2. Mindray Medical (MR): Chinese Medical Device Company that operates in three segments: Patient Monitoring and Life Support, In-Vitro Diagnostic Products, and Medical Imaging Systems. It has a forward PE of 28 and a 5 year estimated growth rate of 39% for a low PEG of 0.72. The stock which has been public for less than 2 years, is near or has passed its all time high.
   

Biotech Breakout?

Over the past several trading days, we noticed that there is positive activity in the bio tech sector.

Amgen (AMGN), over the past four trading days has gone from $47 to $50, a gain of around 6%. The stock has broken out above the 200 day moving average too.

Celgene (CELG), over the past four days has gone from $64 to $69, a gain of around 8%. The stock has broken out above previous resistance levels and is solidly above both the 50 and 200 day moving average.

Genentech (DNA), had broken out, but a recent NY Times Article knocked down the stock today. However, on today's CNBC Mad Money Show, Jim Cramer pushes the Genentech stock and is bullish on bio tech at this part of the cycle.

Gilead (GILD) has shown some recent weakness, but the stock is still above the 200 day moving average and is within 9% of the 52 week high.